关于诊断和管理滴毒素毒性的专家共识
Jason B Hack1, Sue Wingate2, Ron Zolty3
1Brody School of Medicine, East Carolina University, Greenville, Nc.
尽管消毒素的使用减少了,但消毒素的毒性仍然是一个持续的临床问题. 关于诊断和治疗的正式指南,包括严重病例的迪戈辛免疫Fab,现在可用于帮助临床医生.
科学领域:
- 心脏病学 心脏病学
- 医学毒理学医学毒理学
- 临床药理学 临床药理学
背景情况:
- 迪戈辛毒性由于其狭窄的治疗窗口和非特异性症状,提出了诊断和治疗方面的挑战.
- 尽管心力衰竭和心房的狄戈辛使用量有所下降,但毒性仍然是一个重要的临床问题.
研究的目的:
- 制定基于共识的诊断和治疗指南,用于急性和慢性狄戈辛毒性.
- 为了解决围绕着狄戈辛毒性管理的临床不确定性.
主要方法:
- 对34,587篇关于狄戈辛毒性的出版物进行了系统审查,其中114篇符合纳入标准.
- 33个共识陈述由经过修改的Delphi流程开发和评估,涉及专家临床医生.
主要成果:
- 达成一致意见是考虑狄戈辛暴露的时间和性质 (急性,慢性).
- 在危及生命的暴露中,Digoxin immune Fab被推用于降低死亡风险.
- 确定了需要进一步研究和临床关注的几个领域.
结论:
- 提供了正式的指导,以帮助医疗保健提供者管理狄戈辛毒性.
- 这项工作旨在改善临床方法,以应对患者护理中的持续挑战.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
相关概念视频
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
